000 01433 a2200397 4500
005 20250517213713.0
264 0 _c20191025
008 201910s 0 0 eng d
022 _a1756-8722
024 7 _a10.1186/s13045-018-0604-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSun, Weili
245 0 0 _aFirst pediatric experience of SL-401, a CD123-targeted therapy, in patients with blastic plasmacytoid dendritic cell neoplasm: report of three cases.
_h[electronic resource]
260 _bJournal of hematology & oncology
_c05 2018
300 _a61 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdolescent
650 0 4 _aChild
650 0 4 _aDendritic Cells
_xdrug effects
650 0 4 _aFemale
650 0 4 _aHematologic Neoplasms
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aInterleukin-3 Receptor alpha Subunit
_xtherapeutic use
650 0 4 _aRecombinant Fusion Proteins
_xpharmacology
700 1 _aLiu, Huaying
700 1 _aKim, Young
700 1 _aKarras, Nicole
700 1 _aPawlowska, Anna
700 1 _aToomey, Debbie
700 1 _aKyono, Wade
700 1 _aGaynon, Paul
700 1 _aRosenthal, Joseph
700 1 _aStein, Anthony
773 0 _tJournal of hematology & oncology
_gvol. 11
_gno. 1
_gp. 61
856 4 0 _uhttps://doi.org/10.1186/s13045-018-0604-6
_zAvailable from publisher's website
999 _c28350946
_d28350946